LGALS3 and diabetes mellitus: The rare occurrence of diabetes mellitus in ICMP can be explained by an increased level of galectin-3 in the blood (Table 2), which can interact with the insulin receptor and protein glycation products, promoting their utilization, which prevents the development of insulin resistance [22].